Japan Dialysis Market Analysis Report 2022 to 2030

Japan Dialysis Market Analysis

$ 3999

Japan's Dialysis Market is projected to grow from $7.223 Bn in 2022 to $12.411 Bn by 2030, registering a CAGR of 7% during the forecast period of 2022 – 2030. The Japanese government has implemented several policies and regulations to support the development of the dialysis market in the country, such as the Long-term Care Insurance (LTCI) system, which covers the cost of dialysis treatment for eligible individuals, and the Basic Act for Health Insurance, which includes regulations for the provision of dialysis services. Some key players in the Japan dialysis market include Fresenius Medical Care, Baxter International, Nipro Medical Corporation, Nikkiso, Kawasumi Laboratories, and DaVita.

ID: IN10JPPH010 CATEGORY: Pharmaceuticals GEOGRAPHY: Japan AUTHOR: Shivam Zalke

Buy Now

Japan Dialysis Market Executive Summary

Japan's Dialysis Market is projected to grow from $7.223 Bn in 2022 to $12.411 Bn by 2030, registering a CAGR of 7% during the forecast period of 2022–30.

The dialysis market in Japan is a mature market, with a well-established healthcare infrastructure and a high penetration of dialysis treatment. Japan is known for its high-quality healthcare services and advanced technology, which has contributed to the growth of the dialysis market.

Some of the key players in the Japan dialysis market include Fresenius Medical Care, Baxter International, and Nipro Medical Corporation. These companies have a significant presence in the market and offer a wide range of products and services for dialysis treatment. Other notable companies in the market include DaVita, Nikkiso, and Kawasumi Laboratories.

The Japanese government has implemented several policies and regulations to support the development of the dialysis market in the country. Some of these include the Long-term Care Insurance (LTCI) system, which covers the cost of dialysis treatment for eligible individuals, and the Basic Act for Health Insurance, which includes regulations for the provision of dialysis services.

The Japan dialysis market is segmented into Hemodialysis and Peritoneal Dialysis. Hemodialysis is the most common form of dialysis in Japan, accounting for around 85% of the total dialysis market.

Overall, the dialysis market in Japan is expected to continue to grow in the coming years, driven by factors such as an aging population, an increasing incidence of chronic kidney disease, and the government's support for the provision of dialysis services.

japan dialysis market analysis

Market Dynamics

Market Drivers

The Japan dialysis market is driven by several factors, including:

Aging population: Japan has an aging population, and as the population ages, the number of people with kidney failure is expected to increase, which will drive the demand for dialysis treatment
Increasing incidence of chronic kidney disease (CKD): The incidence of CKD in Japan is on the rise due to factors such as diabetes and hypertension, which are becoming more prevalent in the country. This is driving the demand for dialysis treatment.
Government support: The Japanese government has implemented several policies and regulations to support the development of the dialysis market in the country, such as the Long-term Care Insurance (LTCI) system, which covers the cost of dialysis treatment for eligible individuals, and the Basic Act for Health Insurance, which includes regulations for the provision of dialysis services
Advanced technology: Japan is known for its high-quality healthcare services and advanced technology, which has contributed to the growth of the dialysis market. The market is well-established with a high penetration of dialysis treatment
High-quality healthcare services: Japan is renowned for its high-quality healthcare services, which is one of the factors that has contributed to the growth of the dialysis market
Increasing demand for home-based dialysis: With the advancement of technology and increasing awareness, home-based dialysis is becoming more popular in Japan, as it is more convenient and less expensive than in-center dialysis

Overall, these drivers are expected to continue to support the growth of the dialysis market in Japan in the coming years.

Competitive Landscape

Key Players

Some key players in the Japan dialysis market include Fresenius Medical Care, Baxter International, Nipro Medical Corporation, Nikkiso, Kawasumi Laboratories, and DaVita. These companies have a significant presence in the market and offer a wide range of products and services for dialysis treatment.

Fresenius Medical Care is one of the leading players in the market, with a wide range of dialysis products and services, including hemodialysis machines, dialysis concentrates, and dialysis services
Baxter International is another major player in the market, offering a wide range of dialysis products, including hemodialysis machines, dialysis concentrates, and dialysis services
Nipro Medical Corporation is a leading player in the market, offering a wide range of dialysis products, including hemodialysis machines, dialysis concentrates, and dialysis services
Nikkiso is a leading player in the market, offering a wide range of dialysis products and services, including hemodialysis machines, dialysis concentrates, and dialysis services
Kawasumi Laboratories is a leading player in the market, offering a wide range of dialysis products, including hemodialysis machines, dialysis concentrates, and dialysis services
DaVita is a leading player in the market, offering a wide range of dialysis products and services, including hemodialysis machines, dialysis concentrates, and dialysis services

Other notable companies in the market include Nihon Kohden, Terumo, and Asahi Kasei Medical.

Healthcare Policies and Regulatory Landscape

The Japanese government has implemented several policies and regulations to support the development of the dialysis market in the country. Some of these include:

Long-term Care Insurance (LTCI) system: The system covers the cost of dialysis treatment for eligible individuals and aims to increase access to dialysis services
Basic Act for Health Insurance: The act includes regulations for the provision of dialysis services, such as the number of dialysis machines and staff required per facility, and the qualifications of staff providing dialysis services
Medical Devices Act: The act regulates the registration, inspection, and quality control of dialysis equipment and supplies
Pharmaceutical Affairs Law: The law regulates the manufacture, import, distribution, and marketing of dialysis products and supplies
The Health Care and Medical Service Act: The act regulates the healthcare services provided in Japan, including dialysis treatment
The Long-term Care Insurance Act: The act provides coverage for long-term care services, including dialysis treatment
The Medical Service Act: The act regulates the medical services provided in Japan, including dialysis treatment

These policies and regulations have helped to create a favorable environment for the development of the dialysis market in Japan, and are expected to continue to support its growth in the future. Japan's healthcare system is considered one of the best in the world, and the dialysis market is well-established with a high penetration of dialysis treatment. The government's support, the advanced technology, and the high-quality healthcare services are key factors that are expected to drive the growth of the dialysis market in Japan.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Dialysis Market Segmentation

The Dialysis Market is segmented as mentioned below:

By Type (Revenue, USD Billion):

Hemodialysis (HD)
- Conventional Hemodialysis
- Short daily hemodialysis
- Nocturnal hemodialysis
Peritoneal dialysis (PD)
- Continuous Ambulatory Peritoneal Dialysis (CAPD)
- Automated Peritoneal Dialysis (APD)

By Product & Services (Revenue, USD Billion):

Equipment
- Dialysis Machines
- Water Treatment Systems
- Others Dialysis Equipment
Consumables
- Dialyzers
- Catheters
- Other Dialysis Consumables
Dialysis Drugs
Services

By End User (Revenue, USD Billion):

In-center dialysis
Home dialysis

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.